Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank38
3Y CAGR-16.4%
5Y CAGR-5.0%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-16.4%/yr
vs +95.2%/yr prior
5Y CAGR
-5.0%/yr
Recent deceleration
Acceleration
-111.7pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $16.57M | -39.7% |
| 2024 | $27.47M | +1.3% |
| 2023 | $27.11M | -4.5% |
| 2022 | $28.39M | -5.5% |
| 2021 | $30.04M | +40.6% |
| 2020 | $21.36M | +181.8% |
| 2019 | $7.58M | +287.9% |
| 2018 | $1.95M | +193.4% |
| 2017 | $666000.00 | - |